Aerobic biodegradation characteristics and metabolic products of quinoline by a Pseudomonas strain
A bacterial strain, BW003, which utilized quinoline as its sole C, N and energy source, was isolated and identified as Pseudomonas sp. BW003 degraded 192–911 mg/l quinoline within 3–8 h with removal rates ranging from 96% to 98%. The optimum conditions for the degradation were 30 °C and pH 8. In the...
Saved in:
Published in | Bioresource technology Vol. 100; no. 21; pp. 5030 - 5036 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
01.11.2009
[New York, NY]: Elsevier Ltd Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A bacterial strain, BW003, which utilized quinoline as its sole C, N and energy source, was isolated and identified as
Pseudomonas sp. BW003 degraded 192–911
mg/l quinoline within 3–8
h with removal rates ranging from 96% to 98%. The optimum conditions for the degradation were 30
°C and pH 8. In the process of biodegradation, at least 43% of quinoline was transformed into 2-hydroxyquinoline, then 0.69% of 2-hydroxyquinoline was transformed into 2,8-dihydroxyquinoline, and then, presumably, into 8-hydroxycoumarin. Meanwhile, at least 48% of the nitrogen in quinoline was directly transformed into ammonia-N. An extra carbon source enhanced the nitrogen transformation from ammonia-N. Further experiments showed that, besides cell synthesis, BW003 transformed less than 6% of ammonia-N into nitrate through heterotrophic nitrification. In addition, BW003 contained a large plasmid, which may be involved in quinoline metabolism. The study indicates that quinoline and its metabolic products can be eliminated from wastewater by controlling the C/N ratio using BW003 as the bioaugmentation inoculum. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.biortech.2009.05.044 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0960-8524 1873-2976 |
DOI: | 10.1016/j.biortech.2009.05.044 |